The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Counteracted age-related decline in forelimb grip strength and rotarod performance and improved spatial learning in aged mice, without detectable changes in body weight, food intake, fasting blood glucose or spontaneous activity at this low dose (supporting an effect that is largely independent of weight loss or overt metabolic changes).
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
A new study shows low dose GLP-1RA reverses functional and molecular signs of aging in mice.
This indicates that the clear functional benefits are largely specific to aged animals, despite measurable metabolic effects in young mice.